NSCLC drug development

Oncology

Targeted therapies have transformed the treatment landscape for non-small cell lung cancer (NSCLC) over the past decade.

Events

Partner Content

Transforming NSCLC standards of care

News

Shares in GSK fell on a decline in vaccine sales in Q3, although demand for other drugs was strong with signs that its revamp is starting to deliver.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.